2npu: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,328,572 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,328,572 edits
No edit summary
Line 1: Line 1:
[[Image:2npu.jpg|left|200px]]
{{Seed}}
[[Image:2npu.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2npu|  PDB=2npu  |  SCENE=  }}  
{{STRUCTURE_2npu|  PDB=2npu  |  SCENE=  }}  


'''The solution structure of the rapamycin-binding domain of mTOR (FRB)'''
===The solution structure of the rapamycin-binding domain of mTOR (FRB)===




==Overview==
<!--
The mammalian target of rapamycin (mTOR) is a large, multidomain protein kinase, which plays a central role in the regulation of cell growth and has recently emerged as an essential target of survival signals in many types of human cancer cells. Here, we report the solution structures of complexes formed between the FKBP12-rapamycin binding (FRB) domain of mTOR and phosphatidic acid, an important cellular activator of the kinase, and between the FRB domain and a novel inhibitor (HTS-1). The overall structure of the FRB domain is very similar to that seen in the ternary complex formed with FKBP12 and the immunosuppressive drug rapamycin; however, there are significant changes within the rapamycin-binding site with important consequences for rational drug design. The surface of the FRB domain contains a number of distinctive features that have previously escaped attention, including a potential new regulatory site on the opposite face to that involved in the binding of rapamycin, which displays the features expected for a specific binding site for a small molecule. The interaction sites for phosphatidic acid and HTS-1 were found to closely match the site responsible for rapamycin binding. In addition, the structures determined for the FRB-phosphatidic acid and FRB-HTS-1 complexes revealed a striking similarity between the conformations of buried portions of the ligands and that seen for the rapamycin backbone in contact with the domain. Our findings further highlight the importance of the FRB domain in small molecule-mediated regulation of mTOR, demonstrate the ability to identify novel inhibitors of mTOR that bind tightly to the rapamycin-binding site in the absence of FKBP12, and identify a potential new regulatory site that may be exploited in the design of new anticancer drugs.
The line below this paragraph, {{ABSTRACT_PUBMED_17684489}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 17684489 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_17684489}}


==About this Structure==
==About this Structure==
2NPU is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2NPU OCA].  
2NPU is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2NPU OCA].  


==Reference==
==Reference==
Line 31: Line 35:
[[Category: Four-helix bundle]]
[[Category: Four-helix bundle]]
[[Category: Transferase]]
[[Category: Transferase]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 09:45:25 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 10:54:37 2008''

Revision as of 07:54, 28 July 2008

File:2npu.png

Template:STRUCTURE 2npu

The solution structure of the rapamycin-binding domain of mTOR (FRB)

Template:ABSTRACT PUBMED 17684489

About this Structure

2NPU is a Single protein structure of sequence from Homo sapiens. Full experimental information is available from OCA.

Reference

Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR., Veverka V, Crabbe T, Bird I, Lennie G, Muskett FW, Taylor RJ, Carr MD, Oncogene. 2008 Jan 24;27(5):585-95. Epub 2007 Aug 6. PMID:17684489

Page seeded by OCA on Mon Jul 28 10:54:37 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=2npu&oldid=695173"